Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
- Resource Type
- Journal Article
- Source
- Journal of Clinical Oncology; 1/1/2008, Vol. 26 Issue 1, p76-82, 7p
- Subject
- Language
- ISSN
- 0732183X